S&P 500 7,630.72 −0.43%
Nasdaq 25,991.34 −0.07%
S&P/TSX 35,786.24 −0.52%
Apple 346.35 −0.54%
Nvidia 211.75 −0.22%
Microsoft 524.17 +0.59%
Shopify 237.28 +0.37%
Royal Bank 280.92 −0.66%
CAD/USD 0.7147 +0.36%
LIVE · 13:55 ET
Market ClerkRecap
Fri Oct 23 · markets open6 signals today103 insider buys this week · $208.8MCIRO short report next: Oct 31The week ahead

ANIX

Anixa Biosciences Inc
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
3.00
+0.21 +7.73%
USD · Oct 23, 01:40 p.m. ET

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

Who holds it

SEC 13F · LATEST QUARTER PER FUND
None of the 15 tracked funds disclose ANIX in their latest 13F. The funds we follow.

13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.

Stakes of 5% or more

SCHEDULE 13D / 13G · LATEST PER HOLDER · TWO YEARS
No 13D or 13G filing on ANIX in the last two years from the filings we read (13G only for companies we track; the sweep began Sep 2026).

A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.

Watch ANIX. Know when insiders buy.
One email the day a filing lands. Free.